Problems with drugs can take years to discover; more caution is warranted

According to a recent Kaiser Health News analysis, some of the newest most expensive brand-name medicines have been plagued by quality and safety concerns during production. Despite manufacturing concerns, the FDS keeps brand-name drugs on a fast path to market. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.